These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16716111

  • 1. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
    Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J.
    Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
    Xia CF, Bledsoe G, Chao L, Chao J.
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
    Shen B, Hagiwara M, Yao YY, Chao L, Chao J.
    Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
    [Abstract] [Full Text] [Related]

  • 6. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity.
    Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L.
    Hypertension; 2007 Mar; 49(3):490-7. PubMed ID: 17224475
    [Abstract] [Full Text] [Related]

  • 7. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
    Wolf WC, Yoshida H, Agata J, Chao L, Chao J.
    Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
    [Abstract] [Full Text] [Related]

  • 8. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis.
    Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J.
    Nephrol Dial Transplant; 2006 Mar; 21(3):624-33. PubMed ID: 16401625
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J.
    Cardiovasc Res; 2007 Jan 01; 73(1):130-42. PubMed ID: 17137568
    [Abstract] [Full Text] [Related]

  • 11. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J, Zhang JJ, Lin KF, Chao L.
    Hum Gene Ther; 1998 Jan 01; 9(1):21-31. PubMed ID: 9458239
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
    Yao YY, Yin H, Shen B, Chao L, Chao J.
    J Card Fail; 2007 Sep 01; 13(7):588-96. PubMed ID: 17826650
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation.
    Hagiwara M, Shen B, Chao L, Chao J.
    Hum Gene Ther; 2008 Aug 01; 19(8):807-19. PubMed ID: 18554097
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.